Motahari Saeed 4
4 · Insys Therapeutics, Inc. · Filed Apr 19, 2019
Insider Transaction Report
Form 4
Motahari Saeed
DirectorPresident & CEO
Transactions
- Award
Common Stock
2018-03-05+16,000→ 70,986 total - Award
Employee Stock Option (right to buy)
2018-03-05+64,000→ 64,000 totalExercise: $8.06Exp: 2028-03-04→ Common Stock (64,000 underlying) - Award
Employee Stock Option (right to buy)
2019-01-25+282,152→ 282,152 totalExercise: $3.81Exp: 2029-01-24→ Common Stock (282,152 underlying) - Award
Common Stock
2019-01-25+59,206→ 130,192 total
Footnotes (3)
- [F1]The total reported in Column 5 includes 33,000 RSUs previously reported in Table II on the Form 4 filed 4/20/17. Also includes 2,283 and 4,303 shares acquired by the Reporting Person on 12/8/17 and 6/8/18, respectively, pursuant to the Issuer's Employer Stock Purchase Plan.
- [F2]The option vests in 48 equal monthly installments and will be fully vested and exercisable on March 5, 2022.
- [F3]The option vests in 48 equal monthly installments and will be fully vested and exercisable on January 25, 2023.